Bhaskar Anand is Chief Accounting Officer of Summit Therapeutics Inc.. Currently has a direct ownership of 159,751 shares of SMMT, which is worth approximately $3.02 Million. The most recent transaction as insider was on Oct 21, 2025, when has been sold 26,680 shares (Common Stock) at a price of $18.74 per share, resulting in proceeds of $499,983. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K
21.55% 3M change
21.55% 12M change
Total Value Held $3.02 Million

Bhaskar Anand Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 21 2025
BUY
Grant, award, or other acquisition
$499,983 $18.74 p/Share
26,680 Added 14.31%
159,751 Common Stock
Sep 11 2024
BUY
Grant, award, or other acquisition
$499,990 $22.7 p/Share
22,026 Added 14.35%
131,426 Common Stock

Also insider at

RETA
REATA PHARMACEUTICALS INC Healthcare
BA

Bhaskar Anand

Chief Accounting Officer
Plano, TX

Track Institutional and Insider Activities on SMMT

Follow Summit Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SMMT shares.

Notify only if

Insider Trading

Get notified when an Summit Therapeutics Inc. insider buys or sells SMMT shares.

Notify only if

News

Receive news related to Summit Therapeutics Inc.

Track Activities on SMMT